Hong Kong, Khabiir ku takhasusay fayraska Shiinaha ayaa bixiya aragtiyo badan oo ku saabsan omicoron iyo tallaabooyinka ka hortagga

Xigasho: Professor of Economics
Noofambar 24-keedii, virologist iyo Professor of School of Biomedical Sciences, Jaamacadda Hong Kong Li Ka Shing Kulliyadda Daawada, Dong-Yan Jin, waxaa waraystay DeepMed wuxuuna siiyay fikrado badan oo ku saabsan Omicron iyo tallaabooyinka ka hortagga cudurrada faafa.
cilmi-nafsiyeedka
Waxaan hadda heli karnaa gabagabo cad oo ka soo baxay daraasadda Omicron, in dhab ahaantii loo abuuray si ay ula qabsato deegaanka uu jidhka bini'aadamku leeyahay iska caabin.
Ujeedada badbaadadeedu waa in jidhka bini'aadamku uu hore u lahaa difaac, markaa cudur-sidaha jirkiisa waa in si weyn loo yareeyaa.Waxa kale oo la odhan karaa waxay yaraynaysaa cudur-sidaha xaalad ahaan ama kharash si ay u kordhiso baxsiga difaaca si ay u koraan oo ay ugu celceliyaan dadka markii horeba difaacay.Markaa waxay keeni doontaa infekshanno horudhac ah, taas oo ah, dadka la tallaalay weli way qaadi doonaan cudurka, markaa 2021 marka qof walba la tallaalo oo uu leeyahay unugyada difaaca jirka, waxay noqon doontaa nooca ugu weyn.Haddii inta badan dadka adduunka aan la tallaalin oo aan la qaadin, culayska ugu weyn ayaa weli ahaan doona Delta.

Inta badan dadka uu ku dhacay Omicron waxay la kulmaan astaamo u eg hargabka oo inta badan saameeya habka neef-mareenka sare oo aan laga sooci karin hargabka iyo hargabka caadiga ah.Haddii aan la tijaabin antigen ama nucleic acid, way adagtahay in la kala saaro neocoronavirus, fayraska hargabka ama rhinovirus kale ama caabuqyada coronavirus ee keena hargabka caadiga ah.Qaybta caabuqyada asymptomatic-ka ah iyo xaaladaha fudud ee Omicron aad ayay u badan yihiin, taas oo ka dhigan in ka badan 99.5% guud ahaan caabuqyada.

Cudurka Neocoronavirus waa cudur is-xakameyn kara, is-bogsiinaya.Hadda dadka intiisa badan, 99.6% ama ka badan, waa is-xakameyn iyo is-bogsiin.

Ma aha in talaalku gebi ahaanba aan waxtar lahayn, ee waa in talaalku dhinac ka dhimo caabuqa, dhinaca kale, xitaa haddii aanu ka hortegin caabuqa, waxa uu door muhiim ah ka qaadan karaa ka hortagga cudurrada halista ah iyo yaraynta dib u gudbinta. fayraska dadka kale.Si kastaba ha ahaatee, waxa aynu u isticmaalnay in aynu u aragno saamaynta tallaalka sida dhammaan ama waxba, ama ka hortagga infekshanka gebi ahaanba ama gebi ahaanba sidii haddii aan tallaal la helin, iyo warbixinno badan iyo xitaa tarjumaadaha khabiiradu waxay siinayaan fikrad khaldan oo ah in aan si sax ah loo aqoonsan loona fahmin saamaynta ilaalinta badan. ee tallaalada.

Marka la eego xogta cudurka sanadkan ee Hong Kong, haddii hal tallaal oo tallaalka ah aan la siin, heerka dhimashadu waa 2.32%;haddii laba tallaal oo Coxin ah la siiyo, waa 0.36%;laba xabbadood oo Fupirtide ah, waa 0.06%, taas oo ah, lix ka mid ah tobankii kun;haddii laba tallaal oo Coxin ah iyo hal tallaal oo Fupirtide ah la isku daro, waa 0.04%;haddii saddex tallaal oo Coxin ah la bixiyo, waa 0.14%, taasoo aad ugu dhow heerka dhimashada hargabka;afar darbo oo Coxin ah, waa 0.11%.
Samee aashitada nucleic
Ilaa hadda, coronavirus-ka cusub wuxuu jiray ku dhawaad ​​​​saddex sano, waxaan ka soo saarnay bilowgii tijaabada nucleic acid ilaa tijaabada antigen-ka, aad ayey ugu habboon yihiin muwaadiniinta si ay u fuliyaan baaritaanka cusub ee coronavirus, shirkadeena hadda waxay leedahay ugu badansuufka tijaabada nucleic acidsuuqa, waxaa lagu kaydin karaa shaybaarada fayraska heerkulka qolka, iyo sidoo kale coronavirus-ka cusub ee antigen reagents, 15 daqiiqo si ay u soo saaraan natiijooyin, muunad fudud.
Shirkaddeennu waxay ku qalabaysan tahay PCR iyo qalabka lagu ogaado aashitada nucleiic ee ku takhasusay ogaanshaha Neocoronavirus, iyo 96-channel qalab soo saarista aashitada nukliyeerka ayaa si weyn u dardargeliya xawaaraha ogaanshaha!Nala soo xidhiidh haddii aad u baahan tahay.
Xirmada soo saarista Nukliyeerka

hordhaca shirkadda


Waqtiga boostada: Dec-05-2022